Psychiatric Uses of Gabapentin
by Jon C. Martin, DO, and Danielle Gainer, MD Dr. [...]
Letter to the Editor: The Ever-changing Landscape of the Opioid Crisis: Fentanyl and its Analogs
By Adegboyega Oyemade, MD, FAPA Funding/financial disclosures. The author has no [...]
Letter to the editor: Marijuana on the brain— a concern
Dear Editor: Marijuana is one of the most common illegal [...]
Methadone Treatment of Opiate Addiction: A Systematic Review of Comparative Studies
by Shahid Ali, MD; Barira Tahir, MD; Shagufta Jabeen, MD; [...]
When the Opioid Medications Go Missing: Confidentiality and Safety in Adolescents
by Muhammad Hassan Majeed, MD Dr. Majeed is an Attending [...]
Behavioral and Stereological Analysis of the Effects of Intermittent Feeding Diet on the Orally Administrated MDMA (“ecstasy”) in Mice
by Zeinab Ebrahimian, MSc; Zeinab Karimi, MSc; Mohammad Javad Khoshnoud, [...]
Differential Diagnoses: Encephalopathy or Psychosis?
by Malathi Latha Perugula, MD, and Steven Lippmann, MD The [...]
Letter to the Editor: Gabapentin Abuse in a Patient with Comorbid Mood and Substance Use Disorders
Innov Clin Neurosci. 2016;13(7–8):13–14. Dear Editor: Substance use disorders frequently [...]
The Neuroscience Report—Vol. 40 (May 6, 2016): Anti-addiction Medications
The latest in neuroscience—sorted and summarized for you Welcome to [...]
Why Not Pot? A Review of the Brain-based Risks of Cannabis
by Kai MacDonald, MD, and Katherine Pappas, BA Dr. MacDonald [...]